Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Role of IL-32 in Cutaneous T-Cell Lymphoma
Hiraku Suga, Makoto Sugaya, Tomomitsu Miyagaki, et al.
Journal of Investigative Dermatology (2013) Vol. 134, Iss. 5, pp. 1428-1435
Open Access | Times Cited: 60

Showing 1-25 of 60 citing articles:

Genomic profiling of Sézary syndrome identifies alterations of key T cell signaling and differentiation genes
Linghua Wang, Xiao Ni, Kyle Covington, et al.
Nature Genetics (2015) Vol. 47, Iss. 12, pp. 1426-1434
Open Access | Times Cited: 296
Immune cell topography predicts response to PD-1 blockade in cutaneous T cell lymphoma
Darci J. Phillips, Magdalena Matusiak, Belén Rivero‐Gutiérrez, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 157
Interleukin 32, inflammation and cancer
Jin Tae Hong, Dong Ju Son, Chong Kil Lee, et al.
Pharmacology & Therapeutics (2017) Vol. 174, pp. 127-137
Closed Access | Times Cited: 142
Malignant inflammation in cutaneous T‐cell lymphoma—a hostile takeover
Thorbjørn Krejsgaard, Lise M. Lindahl, Nigel P. Mongan, et al.
Seminars in Immunopathology (2016) Vol. 39, Iss. 3, pp. 269-282
Open Access | Times Cited: 129
Transcriptomic and clonal characterization of T cells in the human central nervous system
Jenna L. Pappalardo, Le Zhang, Maggie Pecsok, et al.
Science Immunology (2020) Vol. 5, Iss. 51
Open Access | Times Cited: 98
Insights into the role of IL-32 in cancer
Yvette Sloot, Johannes W. A. Smit, Leo A. B. Joosten, et al.
Seminars in Immunology (2018) Vol. 38, pp. 24-32
Closed Access | Times Cited: 69
Phase I/Ib Study of Tenalisib (RP6530), a Dual PI3K δ/γ Inhibitor in Patients with Relapsed/Refractory T-Cell Lymphoma
Auris Huen, Bradley M. Haverkos, Jasmine M. Zain, et al.
Cancers (2020) Vol. 12, Iss. 8, pp. 2293-2293
Open Access | Times Cited: 58
Thrombospondin-1 promotes tumor progression in cutaneous T-cell lymphoma via CD47
Hiroaki Kamijo, Tomomitsu Miyagaki, Naomi Shishido, et al.
Leukemia (2019) Vol. 34, Iss. 3, pp. 845-856
Closed Access | Times Cited: 56
Molecular interactions and functions of IL-32
Kristin Roseth Aass, Martin H. Kastnes, Therese Standal
Journal of Leukocyte Biology (2020) Vol. 109, Iss. 1, pp. 143-159
Open Access | Times Cited: 55
Deficient Cutaneous Antibacterial Competence in Cutaneous T-Cell Lymphomas: Role of Th2-Mediated Biased Th17 Function
Kerstin Wolk, Hiroshi Mitsui, Katrin Witte, et al.
Clinical Cancer Research (2014) Vol. 20, Iss. 21, pp. 5507-5516
Open Access | Times Cited: 65
Alternatively spliced isoforms of IL-32 differentially influence cell death pathways in cancer cell lines
Bas Heinhuis, Theo S. Plantinga, George Semango, et al.
Carcinogenesis (2015) Vol. 37, Iss. 2, pp. 197-205
Open Access | Times Cited: 55
Tumor-associated M2 macrophages in mycosis fungoides acquire immunomodulatory function by interferon alpha and interferon gamma
Sadanori Furudate, Taku Fujimura, Aya Kakizaki, et al.
Journal of Dermatological Science (2016) Vol. 83, Iss. 3, pp. 182-189
Closed Access | Times Cited: 51
Molecular pathogenesis of Cutaneous T cell Lymphoma: Role of chemokines, cytokines, and dysregulated signaling pathways
Kalyani Patil, Shilpa Kuttikrishnan, Abdul Quaiyoom Khan, et al.
Seminars in Cancer Biology (2021) Vol. 86, pp. 382-399
Open Access | Times Cited: 40
STAT3/5-Dependent IL9 Overexpression Contributes to Neoplastic Cell Survival in Mycosis Fungoides
Pablo Vieyra-Garcia, Tianling Wei, David Gram Naym, et al.
Clinical Cancer Research (2016) Vol. 22, Iss. 13, pp. 3328-3339
Open Access | Times Cited: 43
Multiple myeloma cell-derived IL-32γ increases the immunosuppressive function of macrophages by promoting indoleamine 2,3-dioxygenase (IDO) expression
Haimeng Yan, Mengmeng Dong, Xinling Liu, et al.
Cancer Letters (2019) Vol. 446, pp. 38-48
Closed Access | Times Cited: 41
Aberrant CD137 ligand expression induced by GATA6 overexpression promotes tumor progression in cutaneous T-cell lymphoma
Hiroaki Kamijo, Tomomitsu Miyagaki, Naomi Shishido, et al.
Blood (2018) Vol. 132, Iss. 18, pp. 1922-1935
Open Access | Times Cited: 39
Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension
Paola Di Benedetto, Giuliana Guggino, Giovanna Manzi, et al.
Arthritis Research & Therapy (2020) Vol. 22, Iss. 1
Open Access | Times Cited: 28
Interleukin 32 Promotes Foxp3+ Treg Cell Development and CD8+ T Cell Function in Human Esophageal Squamous Cell Carcinoma Microenvironment
Han Li, Shiyu Chen, Zheyi Chen, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 26
A Paradoxical Effect of Interleukin-32 Isoforms on Cancer
Saerok Shim, Siyoung Lee, Yasmin Hisham, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 18
MHC-I upregulation safeguards neoplastic T cells in the skin against NK cell-mediated eradication in mycosis fungoides
Yun‐Tsan Chang, Pacôme Prompsy, Susanne Kimeswenger, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3
The Role of Cytokines in Cutaneous T Cell Lymphoma: A Focus on the State of the Art and Possible Therapeutic Targets
Alba Guglielmo, Corrado Zengarini, Claudio Agostinelli, et al.
Cells (2024) Vol. 13, Iss. 7, pp. 584-584
Open Access | Times Cited: 3
Pan-cancer analysis reveals IL32 is a potential prognostic and immunotherapeutic biomarker in cancer
Feng Han, Jianxin Ma
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Molecular and Genomic Landscape of Peripheral T-Cell Lymphoma
Javeed Iqbal, Catalina Amador, Timothy W. McKeithan, et al.
Cancer treatment and research (2018), pp. 31-68
Closed Access | Times Cited: 31
A new molecular paradigm in mycosis fungoides and Sézary syndrome
Kojo S.J. Elenitoba‐Johnson, Ryan A. Wilcox
Seminars in Diagnostic Pathology (2016) Vol. 34, Iss. 1, pp. 15-21
Closed Access | Times Cited: 29
IL-32 induces indoleamine 2,3-dioxygenase+CD1c+ dendritic cells and indoleamine 2,3-dioxygenase+CD163+ macrophages: Relevance to mycosis fungoides progression
Hanako Ohmatsu, Daniel Humme, Juana Gonzalez, et al.
OncoImmunology (2016) Vol. 6, Iss. 2, pp. e1181237-e1181237
Open Access | Times Cited: 28
Page 1 - Next Page

Scroll to top